NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
119 hedge funds and large institutions have $833M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 120 → 119 (-1)
12% less capital invested
Capital invested by funds: $951M → $833M (-$118M)
Holders
119
Holding in Top 10
6
Calls
$1.61M
Puts
$24K
Top Buyers
| 1 | +$32.9M | |
| 2 | +$24.9M | |
| 3 | +$10.1M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$8.41M |
| 5 |
Millennium Management
New York
|
+$6.35M |
Top Sellers
| 1 | -$34M | |
| 2 | -$11.9M | |
| 3 | -$6.63M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.5M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$4.2M |